"Wii-Hab" in critically ill children: A pilot trial

"Wii-Hab" in critically ill children: A pilot trial
复制标题

DOI:
10.3233/prm-130260
复制
发表时间:
2013-01-01
影响因子:
1.9
通讯作者:
Choong, Karen
Choong, Karen
中科院分区:
其他
文献类型:
--
作者:
Abdulsatar, Farah;Walker, Rachel G.;Choong, Karen

文献摘要

被引文献

相似文献

目的:评估在儿科重症监护病房(PCCU)环境下,虚拟现实(VR)运动作为一种新的急性康复干预措施的安全性和可行性。方法:3-18岁,预期在PCCU住院48小时,基线正常至中度认知和功能障碍的儿童符合条件。排除标准包括:预期死亡、身体残疾或动员禁忌症。任天堂Wii(TM)拳击处方每天两次,每次至少10分钟,持续两天。结果:在21例符合条件的患者中,12例(57.1%)入选,8例完成研究。男性占41.7%(5/12),中位年龄11岁(3,16)。在接受干预的8名参与者中,有4人在玩Wii(TM)游戏时进行了机械通风。参与者在为期两天的干预期内使用Wii(TM)的中位数为2次(1.5次),总持续时间的中位数为54.5(15,224)分钟。没有可归因于干预的不良事件。Wii(TM)期间的上肢活动量显著高于平均每日活动量(p=0.049)。握力与基线相比没有显著变化(p=0.20)。结论:虽然这项先导性试验的结果表明VR运动可以安全地应用于一部分危重儿童,但我们观察到在这一人群中它的可行性受到了几个威胁。
PURPOSE: To evaluate the safety and feasibility of virtual reality (VR) exercise as a novel acute rehabilitation intervention in a Pediatric Critical Care Unit (PCCU) setting.METHODS: Children aged 3-18 years with an anticipated PCCU stay > 48 hours, and baseline normal to moderate cognitive and functional disability were eligible. Exclusion criteria included: anticipated death, physical inability, or a contraindication to mobilization. Nintendo Wii (TM) Boxing was prescribed for a minimum of 10 minutes twice a day for 2 days. Primary outcomes were feasibility and safety.RESULTS: Of 21 eligible patients, 12 (57.1%) were enrolled and 8 completed the study. 41.7% (5/12) were males, and the median age was 11 (3,16) years. Four of the 8 participants who received the intervention were mechanically ventilated during Wii (TM) play. Participants used the Wii (TM) a median of 2 times (1,5) over the 2-day intervention period, for a median total duration of 54.5 (15, 224) minutes. There were no adverse events attributable to the intervention. Upper limb activity during Wii (TM) was significantly greater than the average daily activity (p = 0.049). Grip strength did not change significantly from baseline (p = 0.20).CONCLUSION: While the results of this pilot trial suggest that VR exercise may be safely applied in a subset of critically ill children, we observed several threats to its feasibility in this population.